Technology: CAR-T therapy, Cell-based gene therapy, Regenerative Medicine
Industry: Biotechnology, Clinical Trials, Medical, Medical Device, Pharmaceutical, Private
Headquarters: Beijing, Beijing, China
Founded Date: 2015-04-01
Employees Number: 1-10
Funding Status: Late Stage Venture
Investors Number: 12
Total Funding: 28064042
Last Funding Date: 2021-11-24
Last Funding Type: Series D

Visit Website
office@immunochina.com
Register and Claim Ownership